CD274 and neoplasm: Future work is also needed to fully understand the role of non-cancer cell derived PD-L1 in creating and sustaining the immune suppressive tumor microenvironment and to uncover novel therapeutic targets that have the potential to improve the efficacy of immunotherapeutic strategies.